SCHEMBL30081022

SCHEMBL30081022

COc1cc2[nH]c(=O)cc(Cl)c2cc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.54
ALDH1A1 P00352 7/20 0.54
HPGD P15428 5/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
MAPT P10636 5/20 0.54
BLM P54132 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
GRIN2D O15399 1/20 0.50
GRIN3B O60391 1/20 0.50
GRIN1 Q05586 1/20 0.50
GRIN2A Q12879 1/20 0.50
GRIN2B Q13224 1/20 0.50
GRIN2C Q14957 1/20 0.50
GRIN3A Q8TCU5 1/20 0.50
PDE3B Q13370 2/20 0.47
PDE3A Q14432 2/20 0.47
MPO P05164 2/20 0.46
XDH P47989 2/20 0.46
AURKA O14965 1/20 0.46
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28314220 1.00 KDM4E (0.54) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL31664560 0.83 KDM4E (0.59) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL28688074 0.83 MAPK10 (0.44) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL19146396 0.81 NQO2 (0.60) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL5473245 0.79 NQO2 (0.54) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL24391685 0.76 KDM4E (0.51) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL28445737 0.76 KDM4E (0.71) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL6678538 0.75 AR (0.57) KDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL31195781 0.74 KDM4E (0.61) KDM4EALDH1A1HPGDSMN1; SMN2MAPT
SCHEMBL7983948 0.74 KDM4E (0.61) KDM4EALDH1A1HPGDSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115362150-A ENPP1 inhibitor, composition and application thereof 贝达药业股份有限公司 2022-11-18 CN disclosed